Table 2

Characteristics of study participants

Intervention (n=40)Control (n=38)
Age61.79±16.0368.82±10.28
Sex
 Male20 (50%)25 (65.8%)
 Female20 (50%)13 (34.2%)
Time post-stroke onset (days)
 Minimum, maximum31, 136917, 1105
 Median (IQR)76 (44.5–130.5)116 (46–170.5)
Cohabitants
 Living alone11/38 (29%)11/37 (30%)
 Spouse only18/38 (47%)20/37 (54%)
 Others9/38 (24%)6/37 (16%)
Carers
 None4/38 (10%)6/37 (16%)
 Professional9/38 (24%)11/37 (30%)
 Family and friends only25/38 (66%)20/37 (54%)
Housing
 House21/38 (55%)23/37 (62%)
 Apartment15/38 (40%)9/37 (24%)
 Other2/38 (5%)5/37 (14%)
Ethnicity
 White British17/38 (45%)19/37 (51%)
 Other White3/38 (8%)8/37 (22%)
 Black Caribbean10/38 (26%)6/37 (16%)
 Other8/38 (21%)4/37 (11%)
NEADL29.89±14.3830.78±17.01
HADS-A7.54±5.277.43±5.10
HADS-D6.90±4.227.11±3.44
SAQOL mean3.37±0.773.25±0.81
SAQOL physical3.40±0.873.05±1.05
SAQOL communication4.00±1.084.09±0.90
SAQOL psychological3.05±1.003.01±1.01
SF-12 physical34.00±8.5330.86±10.10
SF-12 mental46.84±12.5740.96±14.24
SSEQ25.95±8.6423.51±9.72
  • Values are proportion (percentage) or mean±SD, unless otherwise indicated.

  • HADS-A, Hospital Anxiety and Depression Scale—Anxiety scores; HADS-D, Hospital Anxiety and Depression Scale—Depression scores; NEADL, Nottingham Extended Activities of Daily Living Scale; SAQOL, Stroke and Aphasia Quality of Life scores; SF-12, Short Form 12 questionnaire; SSEQ, Stroke Self-Efficacy Questionnaire.